Overview
Sijian Yu practices practicing medicine in Guangzhou, China.
Yu is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Leukemia, Human Papillomavirus Infection, and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 27 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Sijian Yu
Is Sijian Yu a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Sijian Yu is classified as an Advanced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Sijian Yu participate in research or clinical trials?
Yes. Sijian Yu has published 27 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Sijian Yu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)
- Bone Marrow Transplant
- Graft Versus Host Disease (GvHD)
- LeukemiaYu isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)
- Bronchiolitis Obliterans
- Human Papillomavirus Infection